| Nutrition and gastroenteropancreatic neuroendocrine tumors. | |
| | |
MedLine Citation:
|
PMID: 21095548 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are relatively rare neoplasms that characteristically synthesize and secrete an excess of a variety of regulatory peptides, hormones, and neuroamines, which regulate gut and pancreatic function. This excess can lead to distinct clinical syndromes. Therapeutic strategies include surgery, radiofrequency ablation, chemotherapy, chemoembolization, and biotherapy using somatostatin analogs. The clinical syndromes and the various management strategies can lead to altered gut and pancreatic function with nutritional consequences. Diet and nutritional management is critical for GEP NET patients and is the focus of this article. |
| | |
Authors:
|
Vay Liang W Go; Priya Srihari; Leigh Anne Kamerman Burns |
Related Documents
:
|
22110898 - Differentiation syndrome in promyelocytic leukemia: clinical presentation, pathogenesis... 5443968 - Acute scorpion pancreatitis in trinidad. 18813118 - Undifferentiated carcinoma with osteoclastic giant cells (ucocgc) of the pancreas assoc... 11809708 - Lack of wrn results in extensive deletion at nonhomologous joining ends. 16765828 - Quadrigeminal cistern arachnoid cyst in a patient with kabuki syndrome. 10704678 - Complex karyotype and n-ras point mutation in a case of acute megakaryoblastic leukemia... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural |
Journal Detail:
|
Title: Endocrinology and metabolism clinics of North America Volume: 39 ISSN: 1558-4410 ISO Abbreviation: Endocrinol. Metab. Clin. North Am. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8800104 Medline TA: Endocrinol Metab Clin North Am Country: United States |
Other Details:
|
Languages: eng Pagination: 827-37 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
UCLA Center for Excellence in Pancreatic Diseases, Los Angeles, CA 90095-1786, USA. vlwgo@ucla.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
| Grant Support | |
ID/Acronym/Agency:
|
AT003960/AT/NCCAM NIH HHS |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
Next Document: The role of angiogenesis in neuroendocrine tumors.